Skip to search formSkip to main contentSkip to account menu

cytotoxic T-lymphocyte antigen 4

Known as: mdx-ctla4, Cytotoxic T Lymphocyte Associated Antigen 4, Cytotoxic T-Lymphocyte-Associated Antigen 4 
An inhibitory T CELL receptor that is closely related to CD28 ANTIGEN. It has specificity for CD80 ANTIGEN and CD86 ANTIGEN and acts as a negative… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Background Identification of effective treatments in hepatitis B virus (HBV) infection remains a controversial topic. Although… 
2015
2015
In the last decade, discoveries in molecular biology field have allowed new insight into the genes involved in the development of… 
Review
2012
Review
2012
Multiple sclerosis (MS) is a chronic neuroinflammatory autoimmune disease believed to arise from complex interactions of both… 
2011
2011
With recent successes of immunotherapies and targeted drugs, melanoma has become one of the most dynamic areas of anticancer drug… 
2007
2007
Treatment regimens consisting of CTLA‐4 Ig/anti‐CD154 or agonistic anti‐CD28/rapamycin have both been shown to prevent GVHD in… 
2002
2002
Allosensitization is a fundamental problem that limits the effectiveness of blood transfusions. Patients who receive multiple… 
2001
2001
The B7/CD28/CTLA4 pathway plays a critical role in the regulation of T-cell activation and has great potential as a therapeutic… 
2000
2000
Systemic lupus erythematosus (SLE) is characterized by dysregulated activation of both T and B lymphocytes with the development… 
1998
1998
Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4, CD152) is a molecule expressed on in vitro activated T cells. CTLA-4 shares…